Clinical Trial

High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD

Study acronym: HI-MAP
Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Summary
This study will evaluate the feasibility, safety and efficacy of high-intensity inpatient MDMA-assisted psychotherapy for treatment-refractory posttraumatic stress disorder.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-24; most recent amendment 2025-07-23.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-07-23
Trial Details
NCT Number NCT06954025
Lead Sponsor ARQ National Psychotrauma Centre
Collaborators: Leiden University Medical Center
Conditions Posttraumatic Stress Disorder (PTSD)
Enrollment 20 participants
Start Date 2025-05-16
Primary Completion 2026-12 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-24